CELLTRION, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 191,100 KRW | +0.42% |
|
+8.46% | -5.16% |
| Jun. 07 | Celltrion's Avastin Biosimilar Gains 12% Market Share in Japan | MT |
| Jun. 07 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 194,600.00 | 231,500.00 | 214,500.00 |
| Spread/Res. | -1.80% | -17.45% | -10.91% |
| Spread/Supp. | +8.46% | +21.26% | +39.49% |
| Support | 176,200.00 | 157,600.00 | 137,000.00 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- A068270 Stock
- Charts Celltrion, Inc.
